CSF2 and COVID-19: GM-CSF, often abnormally elevated in plasma of severe COVID-19 patients, likely is a main contributor to this pathology, as GM-CSF promotes hematopoietic stem/progenitor cell differentiation into monocytes in the bone marrow, their release into the circulation and their activation.